AMGN vs SPIR · P/E 24, rev $36.75B vs rev $110.5M
Amgen Inc (AMGN) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the AMGN and SPIR stock pages for the full models.
Not investment advice.